TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$4.78M2014: -$3.68M2015: -$23.14M2016: -$65.34M2017: -$75.89M2018: $88.10M2019: -$149.00M2020: -$119.23M2021: $159.98M2022: -$262.88M2023: -$268.13M2024: -$233.35M2025: -$161.20M-$161.20M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$161.20M+30.9%
2024-$233.35M+13.0%
2023-$268.13M-2.0%
2022-$262.88M-264.3%
2021$159.98M+234.2%
2020-$119.23M+20.0%
2019-$149.00M-269.1%
2018$88.10M+216.1%
2017-$75.89M-16.1%
2016-$65.34M-182.4%
2015-$23.14M-528.4%
2014-$3.68M+22.9%
2013-$4.78M—